Stocks · News reference
President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Morris and other companies, agreeing to divest if confirmed.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Why Grindr generates $3M in revenue per employee, beating tech giants like Apple and Meta, and trailing only Nvidia in financial efficiency.
Retail investors talked up 5 hot stocks during week (Sept. 7 to Sept. 11) on X and Reddit's r/WallStreetBets: GME, AAPL, ADBE, ORCL, CASY.
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Apple (AAPL) closed at $332.48, up 1.81% and outperforming the S&P 500's 0.86% gain. The stock has risen 6.98% over the past month. Analysts expect upcoming earnings of $1.98 per share (7.03% YoY growth) and revenue of $112.84 billion (10.12% YoY growth). However, Apple carries a premium valuation with a Forward P/E of 36.89 versus the industry average of 20, and a PEG ratio of 2.79 compared to the industry average of 1.7. The stock holds a Zacks Rank of #3 (Hold).
Eli Lilly's Immunology division generated $2.6 billion in revenues in H1 2026, up 9% year-over-year, representing 6.1% of total revenues. Led by Taltz, the portfolio is expanding through newer products like Ebglyss and Omvoh, plus strategic acquisitions of DICE, Morphic, and Merida to strengthen its pipeline across IBD, autoimmune diseases, and allergies. However, the company faces intense competition from established players and newer therapies.
AbbVie shares are edging higher Friday following Thursday's positive Phase 3 trial results for its menstrual migraine drug, atogepant.